Highlights•UAE and MRgFUS are emerging as safe and effective alternatives to surgical
removal to treat symptomatic uterine fibroid.•Myomectomy remains the gold standard for …

Uterine fibroids are the most common pelvic tumours and the most common benign tumours
in women. Usually diagnosed late in a woman's reproductive life, fibroids are present in up …

Objective To evaluate the effectiveness of uterine‐sparing interventions for women with
symptomatic uterine fibroids who wish to preserve their uterus. Design Systematic review …

Uterine fibroids are the most common tumour in women during the reproductive years,
occurring in an estimated 20–50% of women over the age of 30 years, 1 increasing with age …

Introduction: More women are delaying child-bearing such that gynaecolgists can no longer
resort as frequently to definitive treatments, such as a hysterectomy, in the management of …

Uterine fibroids are common benign tumours that occur in women of reproductive age. They
are frequently associated with symptoms that impact on quality of life and require treatment …

OBJECTIVE To review evidence supporting the use of uterine fibroid embolization (UFE) as
an alternative to hysterectomy and myomectomy for managing uterine fibroids. QUALITY OF …

Minimally invasive treatment options are an important part of the uterine fibroid-treatment
arsenal, especially among younger patients and in those who plan future pregnancies. This …

Review of nonsurgical/minimally invasive treatments for uter... : Current Opinion in
Obstetrics and Gynecology Review of nonsurgical/minimally invasive treatments for uterine …

Uterine fibroids occur in approximately 50% of women over the age of 40 years, and an
estimated 50% of those are symptomatic. Menorrhagia is the most common symptom and …